What are INDmoney investors doing with Concord Biotech shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-6%
Searches for Concord Biotech on INDmoney have decreased by 6% over the last 30 days.
Investment activity on INDmoney
+68.89%
Investment activity in Concord Biotech among INDmoney users has increased by 68.89% over the last 30 days.
Among the most traded stocks
439th
Concord Biotech was the 439th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
16 days
INDmoney investors hold Concord Biotech shares for an average of 16 days.
Key Events for Concord Biotech
Concord Biotech Stock Performance
as on November 18, 2026 at 9:31 pm IST
Day's Low
Day's High
₹545.90₹566.30
2.69%
Downside
0.94%
Upside

52 Week's Low
52 Week's High
₹493.50₹807.50
12.03%
Downside
43.94%
Upside

Concord Biotech share price movements today
- Previous Close
- ₹554.80
- Open
- ₹546.80
- Volume
- 5.70L
- Upper Circuit
- ₹665.70
- Lower Circuit
- ₹443.90
- Day's Low - High
- ₹545.90 - ₹566.30
- 52 Week Low - High
- ₹493.50 - ₹807.50
Concord Biotech Historical Returns
- 1 Month Return
- -13.7 %
- 3 Month Return
- -29.13 %
- 1 Year Return
- -26.09 %
- 3 Year Return
- -9.98 %
- 5 Year Return
- + 17.69 %
Concord Biotech Fundamentals
as on November 18, 2026 at 4:01 pm IST
Market Cap
₹11,608.21 Cr
Return on Equity (ROE)
13.74
PE Ratio (TTM)
41.54
Return on capital employed (ROCE)
18.33
Industry PE ratio
53.94
Beta (LTM)
0.83
P/B Ratio
5.26
Dividend Yield
0.74
PEG Ratio
-19.74
Quarterly Earnings Growth YOY
10.32
EPS (TTM)
12.39
Book Value
96.41
Concord Biotech Stock Valuation
as on November 18, 2026 at 4:01 pm IST
Concord Biotech in the last 5 years
Lowest (20.09x)
August 18, 2023
Today (41.54x)
November 17, 2026
Industry (53.94x)
November 17, 2026
Highest (86.91x)
September 20, 2024
Today’s Price to Earnings Ratio: 41.54x
Concord Biotech Technical Analysis
Track how Concord Biotech technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.31 | Bullish |
CCI (20) | -524.23 | Bullish |
RSI (14) | 38.31 | Neutral |
Momentum (10) | -0.4 | |
ADI (14) | 35.03 | Bullish |
Ultimate Oscillator (7,14,28) | 70.07 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 561.16 | |
EMA (20) | 561.35 | |
VWMA (20) | 561.2 | |
SMA (50) | 562.47 | |
EMA (50) | 562.2 | |
SMA (200) | 562.38 | |
EMA (200) | 562.14 | |
KAMA (200) | 561.55 | |
DEMA (200) | 563.51 |
Concord Biotech Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Concord Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 11,608.21 | 3.54% | 0.50 | 259 | 1,054 | |
| NA | 172.01 | 9.56% | 0.72 | 7 | 140 | |
| BUY | 27,513.70 | 233.78% | 0.57 | 364 | 2,022 | |
| NA | 3,390.39 | 27.48% | 0.58 | 252 | 2,201 | |
| NA | 13.04 | 27.19% | 0.00 | -1 | 18 |
Market expectation of Concord Biotech Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
66.67%
Buy
33.33%
Hold
0.00%
Sell
Concord Biotech Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Concord Biotech Ltd Annual Profit & Loss
Figures in Rupees Crores
Concord Biotech Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Concord Biotech
Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Concord Biotech
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
Altiva Equity Ex-Top 100 Long-Short Fund Direct Growth | ₹11.82 Cr | ₹4.33 Cr (+57.84%) | 1.89% |
Mutual Funds Exiting Concord Biotech
Sorted by largest decrease in holding, month-over-month.
No exiting activity data available right now
Concord Biotech Corporate Actions
View detailed summary of the earnings and dividend history of Concord Biotech.
Concord Biotech Ltd Earnings Results
Concord Biotech Ltd’s net profit jumped 11.12% since last year same period to ₹70.65Cr in the Q2 2026-2027. On a quarterly growth basis, Concord Biotech Ltd has generated 20.71% jump in its net profits since last 3-months.
Read MoreConcord Biotech Ltd Dividends May,2026
In the quarter ending March 2026, Concord Biotech Ltd has declared dividend of ₹7.55 per share on 29 May 2026 - translating a dividend yield of 1.36%.
Read More about Dividends
Indices Featuring Concord Biotech Stock
Check stock indices that include Concord Biotech.
Insights on Concord Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up

Mutual Funds have increased holdings from 5.84% to 5.85% in Nov 2026 quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, 58.53 Cr → 70.65 Cr (in ₹), with an average increase of 17.2% per quarter
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 7.28% to 7.34% in Nov 2026 quarter
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 271.59 Cr → 319.24 Cr (in ₹), with an average increase of 14.9% per quarter
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 44.09% of holdings in Nov 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 1 month, CONCORDBIO stock has moved down by -13.7%
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 37.68% to 37.57% in Nov 2026 quarter
About Concord Biotech Ltd
Revenue: ₹309.07Cr as on September 2026 (Q2 FY27)
Net Profit: ₹69.57Cr as on September 2026 (Q2 FY27)
Listing date: 18 Aug, 2023
Chairperson Name: SUDHIR JAIRAM VAID
| Organisation | Concord Biotech Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | SUDHIR JAIRAM VAID |
| E-voting on shares | Click here to vote |
FAQs
What is Concord Biotech share price today?
Concord Biotech share price today stands at ₹561 as on at the close of the market. Concord Biotech share today touched a day high of ₹566.3 and a low of ₹545.9.
What is the 52 week high and 52 week low range for Concord Biotech share?
Concord Biotech touched a 52 week high of ₹807.5 and a 52 week low of ₹493.5. Concord Biotech share price today i.e. is closed at ₹561, which is -30.53% down from its 52 week high and 13.68% up from its 52 week low.
What is Concord Biotech's market capitalisation today?
Concord Biotech market capitalisation is ₹11,608.21 Cr as on .
How to buy Concord Biotech shares?
To buy Concord Biotech shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for CONCORDBIO or Concord Biotech Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Concord Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Concord Biotech trading volume today?
Concord Biotech trading volume is 5.70L as on . This means that 5.70L shares of Concord Biotech were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Concord Biotech shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest in Concord Biotech has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 16 days. This reflects platform activity only and is not investment advice.